Chinese instructions for Mogamulizumab

Drug name: Mogamulizumab (Mogamulizumab)

Indications:

Moglizumab is a drug used to treat specific types of lymphoma, mainly including the following two indications:

1.Peripheral T-cell lymphoma (Peripheral T-cell lymphoma, PTCL): PTCL is an aggressive type of lymphoma that originates from T lymphocytes. Moglizumab has been approved to treat adult patients with relapsed PTCL, particularly those who have responded poorly to conventional chemotherapy treatments.

2.Cutaneous T-cell lymphoma (Cutaneous T-cell lymphoma, CTCL): CTCL is a rare type of lymphoma that usually affects the skin but may also spread to other tissues and organs. Moglizumab is approved for the treatment of adult patients with relapsed or progressive CTCL, particularly those who have failed or are not suitable for other treatments.

Mechanism of action:

The main mechanism of action of moglizumab is to inhibit the proliferation and survival of malignant T cells by targeting the CCR4 receptor. The CCR4 receptor is often overexpressed in T cell lymphomas. Its mechanism of action includes:

1.Direct inhibition: Moglizumab can bind to the CCR4 receptor, block the signaling pathway within the receptor, and reduce the growth and division of malignant T cells.

2.Immune activation: Moglizumab can also activate the body's immune system, prompting natural killer cells (NK cells) and other immune cells to recognize and attack malignant T cells.

Pharmacology:

The pharmacological characteristics of moglizumab include:

1.Pharmacokinetics: The clearance rate of moglizumab in the body is slow, allowing the effective concentration to be maintained for a longer period of time.

2.Distribution: The drug is mainly distributed in the blood and can enter lymphoma tissue.

3.Metabolism: Moglizumab is metabolized mainly through degradation and clearance.

4.Excretion: Drugs and their metabolites are mainly excreted through the kidneys.

Dosage and usage:

Moglizumab is usually administered intravenously, and the recommended dosage and administration will vary based on the patient's specific condition and weight. The doctor will develop the most appropriate medication plan based on the patient's condition.

Side effects:

Moglizumab may cause some adverse reactions, including but not limited to the following:

1.Skin reactions: including rash, itching, dryness and peeling.

2.Infection: May increase the risk of infection, including bacterial, viral and fungal infections.

3.Nausea and Vomiting: Mild nausea and vomiting may occur.

4.Fatigue: Fatigue and feelings of weakness may occur.

5.Hematological diseases: including thrombocytopenia and leukopenia.

Warnings and Precautions:

During the use of moglizumab, patients and physicians need to monitor closely and pay attention to the following:

1.Skin reaction: If severe skin reaction occurs, notify your doctor immediately.

2.Infection: Patients should avoid contact with infected people and should check for symptoms of infection regularly.

3.Liver function: Monitor liver function and possible signs of liver injury.

4.Allergic reactions: Be alert for allergic reactions, such as urticaria, shortness of breath, etc.

Contraindications:

Moglizumab is contraindicated in the following circumstances:

1.Allergic to any ingredient in the medicine.

2.There is a serious infection.

Drug interactions:

Moglizumab may interact with other drugs, so inform your doctor before use of all medications you are taking, including prescription drugs, over-the-counter drugs, and supplements.

Medicine for special groups:

Special dosage adjustments and monitoring may be required for certain patient populations, such as pregnant women, lactating women, elderly patients, and patients with impaired renal function.

The above are general instructions for moglizumab. Patients should consult a professional doctor before using this drug, develop a personalized treatment plan based on the specific situation, and closely follow the doctor's recommendations and monitoring requirements. This information is for reference only and specific treatment should be carried out according to the doctor's prescription and guidance.